£160.91

It has never been this cheap. We have no record of a lower price.

£161 today · cheaper than every other day in the last 3 months

Springer Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£165.72 £160.43 £161.58 £162.74 £163.89 £165.05 £166.20 25 July 2026 06 August 2026 18 August 2026 30 August 2026 11 September 2026
View at Amazon ↗

Price data last checked 42 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 49 days • 2 price levels

Days at Price
Current Price
4 days · current 45 days 0 11 23 34 45 £161 £166 Days at Price

Price Analysis

Most common price: £166 (45 days, 91.8%)

Price range: £161 - £166

Price levels: 2 different prices over 49 days

Description

This book is based on invited presentations at the Ninth International Catecholamine Symposiwn. Over several decades, each International Catecholamine Symposiwn (ICS) has provided a uniquely important forwn for updating basic as well as clinical research on the catecholamines, dopamine, norepinephrine, and epinephrine. The first ICS took nd n1 place in Bethesda, Maryland, in the USA in 1958; the 2 in Milan, Italy in 1965; the 3 th in Strasbourg, France in 1973; the 4th in Asilomar, California, USA in 1978; the 5 in th th Goteborg, Sweden in 1983; the 6 in Jerusalem, Israel,in 1987; the 7 in Amsterdam, th Netherlands in 1992; and the 8 in Asilomar, California, USA in 1996. th The 9 International Catecholamine Symposiwn (9ICS) was held in Kyoto, Japan, th March 31-April 5, 2001. This ICS was held concurrently with the 5 International th Conference on Progress in Alzheimer's and Parkinson's Disease (5 ADPD). These international meetings were coordinated to be a joint international congress. Catecholamines and related neurotransmitters and neuromediators play important roles in the pathogenesis of symptoms and neurodegenerative processes of Alzheimer's disease and Parkinson's disease. Therefore, the Joint Congress provided an opportunity for investigators and clinicians working in these fields to exchange their· most recent investigational results and clinical experiences. This Joint International Congress turned out to be an enormous success, attended by 1258 participants from 38 countries, in an enthusiastic and pleasant atmosphere.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 October 2002
Listed Since
14 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
99% match

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Springer

£148.21 11 Sep 2026
Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)
97% match

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)

Springer

£151.20 19 Sep 2026
Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)
97% match

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

Springer

£153.12 18 Sep 2026
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
97% match

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Humana

£80.67 21 Sep 2026
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
96% match

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Springer

£128.31 27 Aug 2026
Neurobiology of DOPA as a Neurotransmitter
96% match

Neurobiology of DOPA as a Neurotransmitter

CRC Press

£260.00 27 Aug 2026
Advances in Neuropharmacology: Drugs and Therapeutics
96% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£77.00 26 Sep 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
96% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£106.30 06 Oct 2026
Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)
96% match

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Springer

£248.00 18 Sep 2026
Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)
96% match

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Humana

£149.42 27 Sep 2026
Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)
96% match

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Springer

£213.71 17 Sep 2026
Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)
96% match

Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)

Springer

£84.97 18 Sep 2026
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
96% match

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Humana

£129.99 01 Oct 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
96% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Elsevier

£105.39 12 Sep 2026
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
96% match

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Elsevier

£104.49 01 Oct 2026
Milestones in Neurotoxicity and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu
96% match

Milestones in Neurotoxicity and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu

Elsevier

£57.51 08 Oct 2026
Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)
96% match

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Elsevier

£220.00 18 Aug 2026
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)
96% match

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Springer

£211.22 17 Sep 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
96% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£202.21 18 Aug 2026
Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)
96% match

Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Springer

£109.20 30 Sep 2026
Parkinson's Disease and Movement Disorders
96% match

Parkinson's Disease and Movement Disorders

Lippincott Williams & Wilkins

£176.99 21 Aug 2026
Horizons in Neuroscience Research. Volume 15
96% match

Horizons in Neuroscience Research. Volume 15

£140.29 27 Aug 2026
Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks
96% match

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

£186.89 04 Sep 2026
Nicotinic Acetylcholine Receptors in the Nervous System: 25 (Nato ASI Subseries H:, 25)
96% match

Nicotinic Acetylcholine Receptors in the Nervous System: 25 (Nato ASI Subseries H:, 25)

Springer

£78.01 26 Sep 2026